DIGITAL EDITION

ARCHIVES

Category: Departments

Letters to the Editor: Navigating Desire and Danger: Examining Sexual Violence Vulnerabilities Among Men Who Have Sex With Men and the LGBTQ+ Community on Dating Apps

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Dating apps and other social networks (DSN) that allow individuals to look for love and romance have fundamentally changed the big picture of the

Letters to the Editor: Nocturnal Tactile and Visual Hallucinations Associated with Clonidine Use

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Clonidine is a central acting alpha-2 receptor agonist used for the treatment of psychiatric disorders and sleep difficulties. We report a pediatric patient who

Letters to the Editor: Response to “Validation of a Pediatric Cognitive Assessment Tool to Advance Knowledge on Children’s Cognitive Development, Health Risk Factors, and Health-Promoting Interventions in Sub-Saharan Regions”

Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: We read with great interest the study by Di Cesare et al,1 which introduces the Cognitive Assessment Tool for Pediatric Clinical Research (CAT-PCR), a

Letters to the Editor: Responding to Correspondence on “Validation of a Pediatric Cognitive Assessment Tool to Advance Knowledge on Children’s Cognitive Development, Health Risk Factors, and Health-Promoting Interventions in Sub-Saharan Regions”

Dear Editor: We would like to thank the readers for their thoughtful and constructive comments on our study.1 We believe these observations are highly valuable in guiding test developers in

Letters to the Editor: Medical Errors in Psychiatry: The Case for a Global Perspective

Dear Editor: I read with great interest the article by Pope, “An Overview of Medical Errors in Psychiatry, Part 1: Introduction,”1 published in the January–March 2026 issue of Innovations in

Lessons Learned from Drug Development Programs in Autism: Implications for Future Programs

Innov Clin Neurosci. 2026;23(4–6):10–17. by Gahan Pandina, PhD; William J. Martin, PhD; Christopher Chatham, PhD; Declan Murphy, MD; Jane Myles, MSc; Robert H. Ring, PhD; and Amir Kalali, MD Dr.

Stroke Classification in Brain CT Images Using Transfer Learning With Fastai

Innov Clin Neurosci. 2026;23(4–6):18–36. by Shilpa Bajaj, MCA; Manju Bala, PhD; and Mohit Angurala, PhD Dr. Bajaj is with Applied Sciences (Computer Applications), I.K. Gujral Punjab Technical University, Kapurthala, Punjab,

Managing Sensory Impairments and Communication Differences in Psychotic Disorders

Innov Clin Neurosci. 2026;23(4–6):37–39. by Dominic Theodore, MD, MS; and Nita Bhatt, MD, MPH, DFAPA Dr. Theodore is with Department of Psychiatry, The Ohio State University Wexner Medical Center, Columbus,

Intravenous Ketamine for Treatment-Resistant Depression: A Case Report From a Public Hospital in Argentina

Innov Clin Neurosci. 2026;23(4–6):40–43. By Micaela Dines, MD; Paloma Bamondez, MD; Micaela Montenegro, MD; Pablo Diaz, MD; Ana Laura Ramos, LP; Irene Luis Vega; Gustavo Vazquez, MD, PhD; and Adriana

Shame: An Emotion Needing Exceptional Interventions

Innov Clin Neurosci. 2026;23(4–6):44–50. by Edmund Howe, MD, JD Dr. Howe is Professor of Psychiatry, Uniformed Services University of the Health Science, Bethesda, Maryland. FUNDING: No funding was provided for

A Narrative Review of Nutritional Interventions for Schizophrenia: A Pathway to Personalized Care

Innov Clin Neurosci. 2026;23(4–6):51–55. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan and the Graduate School of

Suzetrigine: A Newly FDA-Approved Non-Opioid Treatment Option for Management of Moderate to Severe Acute Pain

Innov Clin Neurosci. 2026;23(4–6):56–61. by Alexandra R. Rola, PharmD; Jared R. Bagley, PhD; and Emily E. Leppien, PharmD, BCPS, BCPP All authors are with the Binghamton University School of Pharmacy

An Overview of Medical Errors in Psychiatry, Part 2: Preventing and Managing Medical Errors

Innov Clin Neurosci. 2026;23(4–6):62–63. by Charles D. Cash, JD, LLM Mr. Cash is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for

Lessons Learned from Drug Development Programs in Autism: Implications for Future Programs

Innov Clin Neurosci. 2026;23(4–6):9–16. Epub ahead of print. by Gahan Pandina, PhD; William J. Martin, PhD; Christopher Chatham, PhD; Declan Murphy, MD; Jane Myles, MSc; Robert H. Ring, PhD; and

Letters to the Editor: Post-SSRI Sexual Dysfunction: Challenges and Treatment Approaches

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: Selective serotonin reuptake inhibitors (SSRIs) have long been a cornerstone in the treatment of mood disorders, particularly depression and anxiety. Since their introduction in

Letters to the Editor: Response to “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study”

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We read with great interest the study by Fatima and Ilyas,1 which explores the relationship between ethical awareness and burnout among mental health professionals

Letters to the Editor: Responding to Correspondence on “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study”

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: We thank Sah and Kumbhalwar for their careful reading of our article, “Burnout and Ethical Awareness in Mental Health Professionals: A Correlational Study,”1 and

Letters to the Editor: “AI Literacy” is a Deflection of Responsibility

Innov Clin Neurosci. 2026;23(1–3):5–9. Dear Editor: Pierre et al1 carefully document a case of a phenomenon that has received widespread media attention in recent months. The authors correctly note that

Letters to the Editor: Response to “‘AI Literacy’ is a Deflection of Responsibility”

Dear Editor: I thank Dr. Jutla for his comments on our case report1 of artificial intelligence (AI)–associated psychosis. As we predicted, other cases have followed in the academic literature, along

Social Media Use and Technology Use in Patients with Intellectual and Developmental Disabilities

Innov Clin Neurosci. 2026;23(1–3):10–16. by Larrilyn Grant, MD, MS; Lexi Singh, BS; and Anisha Mandava, MS All authors are with the Wright State, University Boonshoft School of Medicine Department of